Buy Kemocarb 150mg Carboplatin Injection IP

Kemocarb 150mg is a Carboplatin Injection IP used for chemotherapy treatments. This 150MG/15ML vial supports cancer therapy with a single-dose format. Kemocarb 150mg injection is a platinum-based chemotherapy drug for cancer treatment.

Strength

150MG/15ML

Pack Size

Storage

Ambient

Manufacturer / TM Owner

FRESENIUS KABI ONCOLOGY LTD

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Carboplatin Injection IP, sold as Kemocarb 150mg, is primarily used in chemotherapy for various cancers including ovarian, lung, and head/neck cancers. It works by interfering with cancer cell DNA replication. Patients often ask what is Kemocarb 150mg used for in cancer treatment. This medication is part of combination regimens for solid tumors.

Side Effects

Kemocarb 150mg may cause nausea, vomiting, or fatigue as common side effects during treatment. Some patients experience low blood cell counts, which can increase infection risk. Hair loss and changes in taste are also reported. These effects vary by individual and treatment duration.

Precautions & Warnings

Kemocarb 150mg should only be handled by healthcare professionals in a clinical setting. Patients must stay hydrated and report unusual symptoms like severe pain or bleeding. Regular blood tests are recommended to monitor side effects. Avoid exposure during pregnancy or breastfeeding.

Avoid Interactions

Kemocarb 150mg may interact with other chemotherapy drugs or medications affecting bone marrow. Alcohol and certain vaccines should be avoided during treatment. Patients on other medications should inform their doctor before starting Kemocarb. Live vaccines are not recommended while using this injection.

References

Frequently Asked Questions

Kemocarb 150mg is a chemotherapy medication used to treat various cancers, including ovarian and lung cancer.

This medication is given as an intravenous injection by healthcare professionals in a clinical setting.

Common side effects include nausea, fatigue, and low blood cell counts.

No, Kemocarb 150mg must be administered by a healthcare provider in a medical facility.

Kemocarb 150mg should be avoided during pregnancy due to potential risks to the fetus.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.